Fig. 5

Kaplan–Meier survival curves constructed based on the three models

Applying the radiomics model, PFS curves for patients with Rad-score ≥ 0.36 (Rad-score = 1) and Rad-score < 0.36 (Rad-score = 0) in the training (a) and validation (b) groups. Applying the genomics model, PFS curves for patients with HRR pathway mutations (HRR = 1) and without (wild-type, HRR = 0) in the training (c) and validation (d) groups. Applying the integrated model, PFS curves for patients with high (Rad_HRR = 2), intermediate (Rad_HRR = 1), and low (Rad_HRR = 0) progression risk in the training (e) and validation (f) groups